Lydia specialises in intellectual property transactions, including licensing, collaboration agreements, joint ventures, consortium agreements, commercialisation arrangements, monetisations and intellectual property aspects of corporate transactions and financings. Lydia is experienced in advising in a wide range of sectors, but has a particular focus on healthcare and life sciences and digital health.
Lydia also specialises in life sciences regulatory compliance, advising on a wide range of issues including product classification, interactions with healthcare professionals, clinical trials (including data protection issues), market access, supply chain requirements, marketing and pharmacovigilance.
Lydia is named as a “Leading Individual” in Life Sciences and Healthcare by Legal 500 and is recognised as a “rising star" by Managing Intellectual Property IP Stars. Lydia has written and spoken extensively about IP and data protection issues related to digital health solutions.
